A New Era in Treating the Chronic Severe Itch of Prurigo Nodularis
/Until recently, there were no FDA-approved systemic therapies for the severe itch and resultant scratching and nodules of the chronic inflammatory skin disease prurigo nodularis (PN). Thanks to two studies led by a University of Miller School of Medicine researcher, the FDA has now approved the monoclonal antibody dupilumab to bring relief — in many cases, life-changing relief — to PN patients.
Read More



